Full-year results will be better than market expects, says Benchmark Aquaculture health, genetics and nutrition company Benchmark Holdings today said it expected full-year results to be significantly ahead of the current market consensus of £15.9 million.
CleanTreat wins seal of approval from Aquaculture Stewardship Council Aquaculture biotechnology company Benchmark Holdings today announced today that it has received the highest level of recognition for environmental protection and sustainability from certification body the Aquaculture Stewardship Council (ASC).
First CleanTreat vessel ready to start work in Norway A vessel equipped with Benchmark’s proprietary CleanTreat filtration system has arrived in Norway ahead of its first commercial deployment.
Novel lice treatment gets green light for use in Norway The novel salmon lice treatment Ectosan Vet has been approved for use in Norway, its developer, Benchmark Holdings, announced today.
New lice treatment wins Norway marketing authorisation Aquaculture biotechnology company Benchmark today announced that is had received marketing authorisation from the Norwegian Medicines Agency (NoMA) for its novel lice treatment Ectosan Vet (BMK08) in Norway.
EU setback for novel lice treatment A doubt has been cast over the commercial introduction of Benchmark’s novel sea lice treatment BMK08 after the European Parliament backed a blocking move by a Green MEP.
Novel lice treatment threatened by European Parliament vote The European Parliament will vote tomorrow on a resolution by Irish Green MEP Grace O’Sullivan that could potentially hamper Norwegian marketing authorisation for Benchmark’s BMK08 sea lice treatment.
Sea lice medicine approval ratified in EU law Aquaculture health, genetics and nutrition company Benchmark Holdings today said that the MRL (Maximum Residue Limit) for its novel sea lice treatment BMK08 has been ratified under European Union law.
Benchmark strengthens team to support lice treatment roll-out Benchmark Animal Health has appointed four new staff to support the operation of its CleanTreat water purification system, which is designed for use with its novel BMK08 lice treatment.
Benchmark signs first CleanTreat agreements Aquaculture health, genetics and advanced nutrition company Benchmark Holdings has signed its first customer agreements for the delivery of its CleanTreat water purification system, it announced today.
New lice treatment method close to commercial launch Aquaculture biotechnology company Benchmark is on track to commercially launch its novel lice treatment for salmon in the second quarter of this year, it said in a financial report today.
Benchmark hires manager to lead Norway lice treatment launch Benchmark Animal Health has appointed a senior manager to lead the Norway commercial launch of its sea lice medicine, BMK08, and its associated CleanTreat water purification system later this year.
Entries open for top aquaculture award Entries have opened for one of aquaculture’s most prestigious competitions, the Innovation Award presented at the world’s biggest aquaculture event, Aqua Nor, in Trondheim, Norway.
Higher revenue and lower costs boost Benchmark An 8% year-on-year increase in revenue and a reduction in costs helped salmon industry egg supplier Benchmark Holdings make adjusted EBITDA of £300,000 in the third quarter of its 2020 financial year.
